Pomide 4mg Capsule Description:
Pomide 4mg is a medication that contains the active ingredient Pomalidomide, which is used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. Here is some information about Pomide 4mg:
Uses:
- Pomide 4mg is used in combination with other medications to treat patients with multiple myeloma who have received at least two prior treatments, including lenalidomide and a proteasome inhibitor, and have not responded to those treatments.
Dosage:
- The dosage of Pomide 4mg may vary depending on the patient’s age, weight, overall health, and the severity of the condition. It is important to follow the dosage instructions provided by the prescribing healthcare provider.
- Pomide 4mg is taken orally as capsules with water, usually once daily on an empty stomach, at least 2 hours before or 2 hours after a meal.
Storage:
- Pomide 4mg should be stored at room temperature (20-25°C or 68-77°F) in a dry place, away from moisture and heat.
- It should be kept out of reach of children and pets.
Side Effects:
- Pomide 4mg may cause some common side effects such as fatigue, diarrhea, constipation, nausea, vomiting, loss of appetite, low blood cell counts (anemia, neutropenia, thrombocytopenia), fever, cough, shortness of breath, rash, muscle or joint pain, and back pain.
- It may also cause some serious side effects such as blood clots, liver toxicity, severe skin reactions, nerve damage, and fetal harm during pregnancy.
Precautions and Warnings:
- Pomide 4mg should not be used during pregnancy as it may cause fetal harm. It is important to use effective contraception during treatment with Pomide 4mg and for at least 4 weeks after discontinuing the medication.
- It is not recommended to breastfeed while taking Pomide 4mg as it may pass into breast milk and harm the nursing infant.
- Pomide 4mg may lower the body’s ability to fight infections, so caution should be exercised to avoid exposure to infections and to promptly report any signs of infection to the healthcare provider.
- Pomide 4mg may cause blood clots, so caution should be exercised in patients with a history of blood clotting disorders or cardiovascular disease.
- Pomide 4mg may cause dizziness, drowsiness, or blurred vision, so caution should be exercised while driving or operating heavy machinery.
Medicine Interactions:
- Pomide 4mg may interact with other medications and substances, including other cancer medications, blood-thinning medications, and drugs that may cause liver toxicity. It is important to inform the healthcare provider about all the medications, supplements, and herbal products being taken before starting Pomide 4mg to avoid potential interactions.
FAQs:
Can I take Pomide 4mg with food?
No, Pomide 4mg should be taken on an empty stomach, at least 2 hours before or 2 hours after a meal.
How long do I need to take Pomide 4mg?
The duration of treatment with Pomide 4mg will be determined by the prescribing healthcare provider based on the individual patient’s response to the medication and the overall treatment plan for multiple myeloma.
Can I drink alcohol while taking Pomide 4mg?
It is not recommended to consume alcohol while taking Pomide 4mg as it may increase the risk of liver toxicity.
Other Information:
- Pomide 4mg is a potent teratogenic drug, which means it can cause severe birth defects or fetal harm if used during pregnancy. Female patients of reproductive age should undergo pregnancy testing before starting Pomide 4mg and use effective contraception during treatment and for at least 4 weeks after discontinuing the medication.
- Male patients taking Pomide 4mg should use condoms during sexual intercourse to prevent exposure of their partner to the drug, as it may be present in semen.
- Pomide 4mg is available in the form of capsules and should be swallowed whole with water, without opening, crushing, or chewing the capsules.
- Pomide 4mg should be used only under the supervision of a qualified healthcare provider who is experienced in the use of cancer medications and who can closely monitor the patient’s response to treatment and manage any potential side effects.
References:
U.S. National Library of Medicine. Pomalidomide. https://pubchem.ncbi.nlm.nih.gov/
Reviews
There are no reviews yet.